BMY vs KOPN · P/E 17, rev $24.46B vs P/E 486, rev $1.7M
Bristol-Myers Squibb Company (BMY) versus Kopin Corporation (KOPN) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Kopin Corporation (KOPN) is a electronic components company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported KOPN revenue for 2026-06-27 was $1.7M. Net income was -$2.9M. KOPN currently screens at market cap $900.6M and trailing P/E 486.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. KOPN currently screens at market cap $900.6M and trailing P/E 486.0.
Not investment advice. Open the BMY and KOPN stock pages for the full models.
Not investment advice.